Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- Institut Pasteur
- Queen Mary University of London
- UCL
- The Francis Crick Institute
- Francis Crick Institute
- Iowa State University
- Liverpool School of Tropical Medicine
- National Institute of Allergy and Infectious Diseases, NIH
- New England HERC
- Stanford University
- Stockholm University
- Texas A&M University
- Texas A&M University System
- The University of Arizona
- Umeå University
- University of Bristol
- University of Cambridge
- University of Liverpool
- University of Maryland, Baltimore
- University of Washington
- Vanderbilt University
- Yale University
- 12 more »
- « less
-
Field
-
remains one of the world’s most important infectious diseases, but the search space for new peptide-based vaccines is enormous. A single parasite proteome can generate millions of possible peptides, and
-
malaria parasites (GAPs) and whole-sporozoite malaria vaccines designed to induce durable protective immunity against Plasmodium infection. Our research combines cutting-edge immunology, parasite biology
-
Taylor. Using simulation-based inference (SBI) with deep learning, UniGEM aims to build a neural network to estimate epidemiological parameters of P. falciparum, the deadliest malaria parasite species
-
Engineering at University College London (UCL). The successful candidates will contribute to the EPSRC Programme Grant Quantum Dot on Silicon Systems for Communications, Information Processing and
-
with the strong-field theory group of Prof. Carla Faria at UCL. The project is supported by the Division of Chemistry at the U.S. National Science Foundation (NSF) as part of the newly launched $10
-
a mouse model, that could rapidly translate to human clinical trials. Our projects focus on understanding the local and systemic adaptive immune responses to this intracellular parasite and resulting
-
University of Liverpool and collaborators at UCL, you will develop, construct and optimise a plasma-liquid reactor based on an existing plasma source design. The role will combine experimental plasma
-
by The Francis Crick Institute, in collaboration with our Partner Universities (King’s College London (King’s), University College London (UCL), and Imperial College London (Imperial)). Crick-PACE
-
, stroke, infections, and neurodegenerative diseases. An independent organisation, its founding partners are the Medical Research Council, Cancer Research UK, Wellcome, UCL, Imperial College London and
-
Statistics, and Mathematical/Theoretical Physics. We expect to make up to 10 appointments at the University of Bristol , Imperial College London , King’s College London , UCL , and the University of